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Influenza virus NS2 is well known for its role in viral ribonucleoprotein nuclear export; 
however, its function has not been fully understood. A recent study showed that NS2 
might interact with HIST1H1C (H1C, H1.2). Histones have been found to affect influenza 
virus replication, such as the H2A, H2B, H3, and H4, but H1 has not been detected. 
Here, we found that H1C interacts with NS2 via its C-terminal in the nucleus and that 
H1C affects influenza virus replication. The H1N1 influenza virus replicates better in H1C 
knockout A549 cells compared to wild-type A549 cells, primarily because of the regu-
lation of H1C on interferon-β (IFN-β). Further studies showed that the H1C phosphory-
lation mutant (T146A) decreases IFN-β, while H1C methylation mutants (K34A, K187A) 
increases IFN-β by releasing the nucleosome and promoting IRF3 binding to the IFN-β 
promoter. Interestingly, NS2 interacts with H1C, which reduces H1C–IRF3 interaction 
and results in the inhibition of IFN-β enhanced by H1C. In summary, our study reveals a 
novel function of H1C to regulate IFN-β and uncovers an underlying mechanism, which 
suggests H1C plays a role in epigenetic regulation. Moreover, our results suggest a novel 
mechanism for the influenza virus to antagonize the innate immune response by NS2.
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inTrODUcTiOn
The influenza virus NS2, whose most important role is to regulate viral ribonucleoprotein nuclear 
export, affects influenza virus polymerase activity. However, its function has not been fully under-
stood, and in-depth studies are needed to further elucidate its functions and the mechanism. A 
recent study on the influenza A virus NS2 demonstrated that it potentially interacts with host factors, 
including HIS1H1C (H1C, H1.2) (1). Histones have been recognized for their abundant effects on 
the host cell and pathogens. Hoeksema et al. found that histones H3 and H4 neutralize influenza 
virus in a more robust manner compared to H2A and H2B (2), while histone H1 has not been 
detected. These findings indicate that H1C may affect influenza virus replication.
H1C belongs to the histone H1 family, interacts with linker DNA between nucleosomes, and 
plays a role in the compaction of chromatin into higher order structures (3, 4). Previous studies 
have demonstrated that H1C can be phosphorylated by DNA-dependent protein kinase at the T146 
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amino residue (5) and methylated by euchromatic histone-lysine 
N-methyltransferase (EHMT1/2) at the K34 and K187 amino 
residues (6). EHMT1/2 are components of the E2F6 complex, 
which repress gene transcription and participate in regulation of 
the cell cycle (7, 8). H1C participates in apoptosis, which is mainly 
induced by DNA damage (9–11). Recently, H1C phosphorylation 
was found to regulate p53 acetylation and plays a role in DNA 
damage repair (12); however, the function of H1C methylation 
is still unknown.
Typically, viruses can produce pathogen-associated molecular 
patterns (PAMPs) during replication (13, 14); PAMPs then inter-
act with various pattern recognition receptors (PRRs) in the cell 
membrane and cytoplasm. Following PAMP recognition, PRR-
induced signal transduction activates antiviral genes transcrip-
tions (13, 15, 16). Influenza virus can be recognized by RIG-I 
and activates the innate immune response, ultimately inducing 
interferon-β (IFN-β) production (17). However, influenza virus 
can also inhibit IFN-β via different mechanisms; for example, 
NS1 protein can target tripartite motif-containing protein 25 
(TRIM25) and riplets ubiquitin E3 ligases in a species-specific 
manner to drive the inhibition of RIG-I ubiquitination and anti-
viral IFN production (18). Recently, histones have been found 
to participate in the regulation of innate immunity; for instance, 
extrachromosomal histone H2B interacts with IFN-β promoter 
stimulator 1, which is engaged in the signaling pathway initiated 
by dsDNA to trigger antiviral innate immune responses (19). 
However, the effect of H1C on innate immune response has not 
been revealed.
Here, we performed experiments to investigate the effect of 
H1C on influenza virus replication and found that H1C inhibits 
H1N1 influenza virus replication. The virus replicates better in 
H1C knockout (H1C-KO) A549 cells compared to wild-type 
cells. Further data showed that H1C is involved in the innate 
immune response and regulates IFN-β by interacting with IRF3. 
Interestingly, H1C interacts with NS2 via its C-domain in the 
nucleus, and NS2 reduces H1C–IRF3 interaction and inhibits 
IFN-β induced by H1C.
MaTerials anD MeThODs
cells and Viruses
Human embryonic kidney 293 T (HEK293T) cells, Henrietta Lacks 
strain of cancer cells (HeLa), and adenocarcinomic human alveolar 
basal epithelial cells (A549) are maintained in DMEM (Gibco, New 
York, NY, USA), 1640 and F12 (HyClone, Beijing, China) medium 
supplemented with 10% fetal bovine serum, and cultured at 37°C 
under 5% CO2. Influenza A virus H1N1 [A/WSN/1933(H1N1)] 
(WSN) was obtained by reverse genetics as described by Hoffmann 
and Webster (20) and maintained by our laboratory. Sendai virus 
(Sev) was kindly provided by Professor Zhengfan Jiang (Institute 
of Life & Science, Peking University, China).
Plasmids and small interfering  
rna (sirna)
The H1C open reading frame (NCBI, NM_005319.3) 
was amplified by PCR using the primers H1C-EcoRI 
(AAAgaattcaATGTCCGAGACTGCTCCTGCCG) and H1C-
BamHI (AAAggatccTTTCTTCTTGGGCGCCGCCTTCT) and 
cloned into the p3Xflag-CMV vector. The H1C mutants (K34A, 
T146A, K187A, H1C-NT, and H1C-CT) were constructed by 
PCR using primer star (Takara, Tokyo). The GFP fusion plasmids 
GFP-H1C, GFP-H1C-NT, and GFP-H1C-CT were constructed 
as described above. The nucleotide sequence of the NS2 protein 
of A/WSN/1933(H1N1) was synthesized according to a sequence 
in GenBank (U13682.1) and cloned into the pCAGGS-HA 
vector. The plasmids pDsRed-NS2, pDsRed-NS2-NT, and 
pDsRed-NS2-CT were constructed as described above. siRNA 
targeted to H1C (si-H1C) was used and the sequence was as 
follows: 5′-UUUUUCUCCACAUCAUAGCCG-3′; a non-target 
siRNA was used as negative control (si-NC), and the sequence 
was as follows: 5′-UUCUCCGAACGUGUCACGUTT-3′; 
a siRNA targeted to GAPDH was used as a positive 
control (si-GAPDH), and the sequence was as follows: 
5′-UGACCUCAACUACAUGGUUTT-3′.
Transfection
Transfection was performed using lip2000 reagent according to 
the manufacturer’s instructions. Both plasmids or siRNA and 
lip2000 reagent were diluted with equal value of opti-MEM 
medium and kept for 5 min at room temperature, following by 
mixing them generally, Next, the mixture was added into plates 
after 20 min, and cells were cultured with fresh medium with or 
without serum at 6 h post-transfection.
immunofluorescence (iF) confocal 
Microscopy
Immunofluorescence confocal microscopy was performed 
as described (21). HeLa or A549 cells were fixed with 4% 
paraformaldehyde for 10 min, treated with 2‰ Triton-X100 for 
10 min, and incubated with 1% BSA for 1 h at room tempera-
ture. The sample was then incubated with specific antibodies 
[anti-Flag mouse monoclonal antibody (Sigma, F3165, USA), 
anti-HA rabbit polyclonal antibody (PMK Bio., PMK013C, 
China), anti-NS2 mouse polyclonal antibody (prepared by our 
lab), and anti-H1C rabbit polyclonal antibody (Proteintech, 
19649-1-AP, China)] for 2 h followed by incubation with goat 
anti-mouse FITC-labeled and goat anti-rabbit Cy3-labeled sec-
ondary antibodies (KPL, No. 172-1806-1, No. 072-01-15-06-1, 
USA). Finally, images were acquired using confocal microscopy 
(LSM510 ZEISS, Germany).
co-immunoprecipitation (co-iP)
A549 cells were infected with influenza virus at an MOI of 10 and 
lysed at 10 h post-infection. Co-IP was performed as described 
(22) using the NS2 polyclonal antibody, and sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and 
western blotting analyses were performed. To demonstrate the 
H1C–NS2 interaction, HEK293T cells were co-transfected with 
Flag-H1C and HA-NS2, and Co-IP was performed as described 
above using an anti-HA antibody and analyzed using western 
blotting using anti-Flag antibody. To detect the H1C–IRF3 
interaction, HEK293T cells were transfected with HA-IRF3 and 
TaBle 1 | Primers used for rT-Pcr.
gene name Forward sequences (5′–3′) reverse sequences (5′–3′)
H1C GGCAGCCTCCGGGGAAGC CGGCTTCTTCGCTTTCTTCGGTG
NP GCGTTCAGCCCACTTTCTCG GGGTTCGTTGCCTTTTCGTC
GAPDH GCTAAGGCTGTGGGCAAGG GGAGGAGTGGGTGTCGCTG
β-actin CAGGGCGTGATGGTGGGCA CAAACATCATCTGGGTCATCTTCTC
Interferon-β GCTCCTGTGGCAATTGAATGG TTGGCCTTCAGGTAATGCAG
IL-6 ACAGCCACTCACCTCTTCAGAAC GCTCTGGCTTGTTCCTCACTACTC
IL-8 TGCAGCTCTGTGTGAAGGTG CAGCCCTCTTCAAAAACTTCTCC
TNF-α CAGGCGGTGCTTGTTCC AAGAGGACCTGGGAGTAGATGA
OASL GCCTTCTCTTCCCAACTCCC AGGCATAGATGGTTAGAAGTTCAAGA
MX1 CCGAGGGAGACAGGACCAT CGTGGCCTTTCCTTCCTCC
CXCL10 ATTTGCTGCCTTATCTTTCTGACTCTA TGGCCTTCGATTCTGGATTCA
The gene sequences are downloaded from NCBI, and primers are designed by Primer 5.
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Flag-H1C or its mutants and infected with Sev at 24  h post-
transfection and lysed for IP at 12  h post-infection using an 
anti-Flag monoclonal antibody.
subcellular Fractions extraction
Subcellular fractions were extracted as described (23). A total 
of 106 HEK293T or A549 cells treated accordingly were har-
vested and lysed with 100 µL of cytoplasmic extraction buffer 
on ice for 20 min followed by the addition of NP-40 (Amresco, 
Solon, USA) at a final concentration of 0.5%, and the sample 
was vortexed for 15  s. Next, the sample was centrifuged for 
10 min at 3,500 g at 4°C, and the supernatant was stored as the 
cytoplasm fraction. The pellet was dissolved in 80 µL nucleus 
extraction buffer and incubated on ice for 10  min followed 
by centrifugation for 10  min at 14,000  g at 4°C. Finally, the 
supernatant was collected and stored as the nuclei fraction 
until further analyses.
rna Quantitation rT-Pcr analysis
Cells were lysed with TRIzol Reagent (Invitrogen, USA), and the 
total RNA was extracted according to the manufacturer’s instruc-
tions. Two micrograms of RNA was used to generate cDNA using 
reverse transcriptase (AMV XL TaKaRa, Tokyo) with oligo-dT-
18T. Then, the cDNA was used as a template for real-time PCR 
(ABI Vii7A, USA), and the level of the target gene was normalized 
to the housekeeping gene glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) or β-actin. The sequences of primers used for 
RT-PCR are given in Table 1.
Viral growth curve Measurement
A549 cells in 12-well plates were transfected with plasmids 
(1 µg) or siRNA (40 pmol) and then infected with influenza 
virus at an MOI of 0.01. The samples were harvested at 12, 24, 
36, and 48 h post-infection. A plaque assay was performed as 
described (24), and the cells were cultured until the plaques 
had distinctly formed. Finally, the number of plaques was 
quantified.
Western Blotting analysis
Equal amount protein of each sample was loaded for SDS-PAGE, 
and protein was transferred from the gel onto a nitrocellulose 
filter membrane, followed by blotting with specific antibodies. 
Finally, a Chemiluminescence Imaging System (DNR, USA) was 
used for the analysis and images were acquired.
chromatin immunoprecipitation and 
Quantitation Pcr (chiP-qPcr)
Human embryonic kidney 293 T  cells were co-transfected 
with HA-IRF3 and Flag-H1C or its mutants and ChIP-
qPCR was performed as described (25) using an anti-HA 
monoclonal antibody. A mouse monoclonal poly II antibody 
(EPITOMICS, 2035-1, CA, USA) served as the positive 
control, and a blank mouse IgG (ZKCY 161025, Beijing 
China) served as the negative control. The primer sequences 
(IFN-β promoter) used in this experiment were as follows: 
forward, 5′-TAGGAAAACTGAAAGGGAGAAG-3′; reverse, 
5′-TGTCGCCTACTACCTGTTGTG-3′.
construction of the h1c-KO cell line
The H1C-KO A549 cell line (A549-H1C-KO) was constructed 
using the CRISPR/Cas9 system (26), and the guide sequence 
was as follows: 5′- AACCAATGTCACCGGCGCCGGCC- 3′, 
5′- TTGGTTACAGTGGCCGCGGCCGG- 3′. A549 cells were 
transfected with px335-H1C plasmid and cultured for 2  days. 
This was repeated twice, and the cells were digested, highly 
diluted, and cultured in a 48-well plate until the cells had grown 
as a monolayer. Finally, these cells were analyzed by PCR and 
western blotting to investigate whether H1C was knocked out, 
and the positive cells were used for further experiments.
statistical analysis
The data were presented as the mean ± SD of three independent 
experiments, and statistical significance was determined using 
two-way ANOVA. A p-value less than 0.05 was considered statis-
tically significant (*p < 0.05, **p < 0.01, ***p < 0.001).
FigUre 1 | investigation of the interaction between h1c and ns2. (a) A schematic diagram of the H1C and NS2 substitutions, the phosphorylation site 
(T146) or methylation site (K34 and K187) of H1C were mutated, and H1C was divided into the N-terminal and C-terminal regions. NS2 was also divided into the 
N-terminal and C-terminal regions. (B) Human embryonic kidney 293 T (HEK293T) cells were transfected with HA-NS2 and Flag-H1C or its mutants, and a 
co-immunoprecipitation (Co-IP) experiment was performed using anti-HA antibody to detect the interactions. (c) HeLa cells cultured on slides were co-transfected 
with HA-NS2 and Flag-H1C or its mutants, and immunofluorescence confocal microscopy was performed 24 h later using anti-Flag mouse monoclonal antibody 
and anti-HA rabbit polyclonal antibody followed by immunostaining with FITC-labeled goat anti-mouse secondary antibody and Cy3-labeled goat anti-rabbit 
antibody. (D) Detection of the phosphorylation levels of the H1C phosphorylation mutant. H1C or H1C-T146A expressed in HEK293T cells were immune-
precipitated using the anti-flag monoclonal antibody (Sigma, F1804, USA) and analyzed by western blotting using the threonine phosphorylation antibody.  
(e) Detection of the methylation levels of H1C methylation mutants. H1C, H1C–K34A, or H1C–K187A expressed in HEK293T cells were immune-precipitated using 
the anti-flag antibody and detected by western blotting using the methylation antibody.
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resUlTs
ns2 interacts with h1c
To confirm the interaction between NS2 and H1C, HA-NS2 and 
Flag-H1C were co-expressed in HEK293T  cells, and a Co-IP 
experiment was performed using the anti-HA monoclonal 
antibody. The data showed that NS2 really interacted with H1C. 
To further investigate the interaction domains of them, H1C was 
divided into regions, the N-terminal (H1C-NT) and C-terminal 
(H1C-CT). In addition, the phosphorylation (T146A) or meth-
ylation (K34A, K187A) mutants were generated. Furthermore, 
NS2 was divided into N-terminal (NS2-NT) and C-terminal 
(NS2-CT) regions (Figure 1A). When using wild-type HA-NS2 
to immune-precipitate Flag-H1C and its mutants, it could only 
interact with the C-terminal of H1C but had no interaction 
with the N-terminal of H1C, indicating that H1C interacted 
with NS2 via its C-domain. Moreover, when tested with H1C 
phosphorylation and methylation mutants, NS2 showed inter-
actions with all these mutants; the T146A mutation decreased 
the interaction compared with H1C wild type, while the K187A 
mutation increased the interaction. The K34A mutants slightly 
weakened this interaction (Figure 1B). To investigate whether 
NS2 and H1C or its mutants co-localized in the cell, HA-NS2 and 
Flag-H1C or its mutants were co-expressed in HeLa cells and IF 
confocal microscopy was performed as described previously. The 
data showed that H1C and its mutants localized in the nucleus, 
and NS2 localized in the whole cell but predominantly in the 
nucleus. NS2 showed good co-localization with H1C and K34A, 
T146A, K187A, and H1C-CT mutants in the nucleus but little co-
localization with H1C-NT, although the two proteins were both 
localized in the nucleus (Figure 1C). In addition, to confirm the 
phosphorylation or methylation mutation, the phosphorylation 
FigUre 2 | investigation of the interaction domain of ns2 and the interaction between ns2 and endogenous h1c. (a) Human embryonic kidney 293 
T cells were transfected with Flag-H1C and RFP-NS2 or its mutants, and a co-immunoprecipitation (Co-IP) was performed to detect interactions using the anti-flag 
antibody. An anti-RFP antibody was used to detect pDsRed-NS2 or its mutants. (B) HeLa cells cultured on slides were co-transfected with pEGFP-H1C and 
pDsRed-NS2, pDsRed-NS2-NT, or pDsRed-NS2-CT, and confocal microscopy was performed 24 h later to detect the co-localization. (c) A549 cells were infected 
with influenza virus for 10 h (WSN,MOI = 10), and an IP experiment was performed using an anti-NS2 antibody to detected the interaction between NS2 and 
endogenous H1C. Histone H4 (H4) served as a negative control. (D) A549 cells were treated as described above, and confocal microscopy was performed using 
the anti-NS2 mouse polyclonal antibody and anti-H1C rabbit polyclonal antibody followed by immunostaining with FITC-labeled goat anti-mouse secondary 
antibody and Cy3-labeled goat anti-rabbit antibody to detect its co-localization.
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and methylation levels of the proteins were detected and indicated 
that the mutation of the T146 residue resulted in a loss of H1C 
phosphorylation (Figure 1D). However, the methylation ability 
was weakened when the K34 or K187 residues were individually 
mutated (Figure 1E).
The above data showed that H1C interacted with NS2 via 
its C-domain, but by which domain does NS2 interacts with 
H1C? To answer this question, NS2 was divided into the NT 
and CT domains and fused with an RFP tag because the con-
structs were too small to be detected using western blotting. 
Next, Flag-H1C and RFP-NS2, RFP-NS2-NT or RFP-NS2-CT 
were co-expressed in HEK293T cells, and Co-IP experiments 
were performed, and these results showed that only full-length 
NS2 could interact with H1C (Figure  2A). Again, confocal 
microscopy was performed to observe the co-localization of the 
proteins, demonstrating that GFP tagged H1C was granularly 
distributed in the nucleus, and co-localized with RFP fused NS2. 
The NS2-NT lost the ability to localize in the nucleus compared 
with wild-type NS2, while NS2-CT was distributed throughout 
the cell, and both of the proteins showed little co-localization 
with H1C (Figure 2B). Moreover, to investigate the interaction 
between NS2 and endogenous H1C during infection, A549 
cells were infected with influenza virus (WSN), and a Co-IP 
experiment was performed using the NS2 polyclonal antibody. 
The data revealed that NS2 interacted with endogenous H1C 
during infection. To further confirm whether this interaction 
is specific, another histone protein was used for detection and 
the data showed that NS2 had no interaction with histone 
H4, which indicated that NS2 specifically interacted with 
H1C (Figure 2C). In addition, results obtained from confocal 
microscopy showed that the proteins were co-localized in the 
nucleus during infection (Figure 2D).
h1c regulates influenza Virus replication
As H1C interacts with NS2 and histones play a role in influenza 
virus replication, suggesting that H1C may involve in the regula-
tion of influenza virus replication. To investigate this question, 
A549 cells were transfected with siRNA, H1C or its mutants and 
infected with influenza virus, and NP mRNA and expression levels 
were detected. The result showed that NP mRNA was significantly 
increased when silencing H1C but significantly decreased when 
overexpressing H1C. Interestingly, the K34A and K187A mutants 
reduced virus replication more significantly compared with H1C, 
while the T146A mutant reduced the inhibition of H1C on viral 
replication (Figure 3A). To further confirm these observations, 
western blotting analyses were performed, and the results showed 
FigUre 3 | The effect of h1c on influenza a viral replication and proliferation in a549 cells. (a) A549 cells transfected with small interfering RNA (siRNA), 
H1C or its mutants were infected (WSN, MOI = 0.01); and the samples were collected at 12, 24, and 36 h, respectively. Next, real-time PCR was performed to 
detect the NP mRNA levels. A non-target siRNA (Si-NC) and the siRNA targeted to GAPDH (Si-GAPDH) were used as negative or positive controls, respectively, to 
detect the silencing specificity of H1C. (B) Cells were treated as described above, and western blotting analyses were performed to detect the NP expression level. 
(c) Detection of H1C silencing using real-time PCR. (D) One step viral growth curve detection on A549 or A549-H1C knockout (H1C-KO) cells. A549 and 
A549-H1C-KO cells were infected with influenza virus (WSN, MOI = 0.01). The supernatants were then collected at 12, 24, 36, and 48 h post-infection, and the viral 
titers were detected using the plaque assay on MDCK cells (*p < 0.05, **p < 0.01, the data were generated from three independent experiments).
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that the NP expression level of the H1C-silenced group was much 
higher compared to the Si-NC group, while overexpression of 
H1C significantly reduced NP expression levels compared with 
the vector group. These findings were consistent with the results 
of the mRNA levels (Figure 3B). The silencing efficiency of H1C 
was detected using real-time PCR, and it showed that H1C was 
specifically silenced during infection (Figure 3C); the Si-NC and 
Si-GAPDH groups were served as negative or positive controls. 
To better understand the effect of H1C on influenza A virus, 
H1C-KO A549 cells (A549-H1C-KO) were generated using 
Crisp/cas9. In addition, the virus growth curve was measured in 
both A549 wild-type and knockout cell lines. Expectedly, virus 
proliferated more robustly in A549-H1C-KO cells compared to 
A549 wild-type cells (A549-WT) (Figure 3D). The H1C expres-
sion was detected by western blotting, and it showed that H1C 
was successfully knockout. However, when H1C was expressed 
in A549-H1C-KO cells, the virus titer was significantly inhibited. 
Moreover, K34A and K187A mutations significantly enhanced 
the inhibitory ability of H1C on virus titer, while the T146A 
mutation relieved this inhibition (Figure 4A). Furthermore, NP 
mRNA levels were also detected, and these results were consist-
ent with that of the virus titer (Figure 4B). In addition, a similar 
result was found when examining the NP expression levels by 
western blotting (Figure 4C).
h1c is involved in the regulation of iFn-β
To explore the mechanism underlying H1C inhibition of 
influenza virus replication, the virus-related cytokines and 
chemokines were detected because they play an important 
role in the antiviral process, and histones might be involved in 
the innate immune response. A549 cells were transfected with 
siRNA, H1C or its mutants, and RT-PCR was performed to 
detect those genes mRNA levels. These data showed that H1C 
significantly upregulated IFN-β and K34A, and K187A mutants 
enhanced this ability, while the T146A mutation significantly 
decreased this upregulation. However, silencing or overexpress-
ing H1C or its mutants showed little effect on MX1. In addi-
tion, H1C had little effect on OASL, IL-8, and IL-6 production. 
Moreover, TNF-α was significantly increased when H1C, K34A, 
and K187A mutants were overexpressed and were significantly 
inhibited when H1C was silenced. In addition, overexpression 
of H1C increased CXCL10 expression (Figure 5). Because H1C 
had a more significant effect on IFN-β than other cytokines and 
IFN-β plays an important role in the antiviral process, further 
FigUre 4 | investigation of the effect of h1c on influenza a viral replication and proliferation in a549-h1c-KO cells. (a) A549-H1C-KO cells transfected 
with H1C or its mutants were then infected with influenza virus (WSN, MOI = 0.01). The supernatants were collected at 12, 24, and 36 h post-infection, and the viral 
titers were detected using plaque assay on MDCK cells. (B) A549-H1C-KO cells were treated as described above, and the RNA was collected at 12, 24, and 36 h 
post-infection, and NP mRNA was detected using real-time PCR. (c) Cells were treated as described above, and western blotting analyses were conducted to 
detect the NP expression levels (*p < 0.05, **p < 0.01, the data were generated from three independent experiments).
7
Liu et al. NS2 Antagonizes IFN-β Induced by HIST1H1C
Frontiers in Immunology | www.frontiersin.org March 2017 | Volume 8 | Article 350
experiments were performed to determine how H1C regulates 
IFN-β. The IFN-β mRNA levels were detected when H1C was 
silenced or overexpressed on A549 cells, and the data showed that 
IFN-β production was reduced when H1C was silenced, while it 
was increased when H1C was overexpressed. Interestingly, K34A 
and K187A substitutions enhanced the ability of H1C to induce 
IFN-β, while the T146A mutation significantly inhibited the 
ability of H1C to induce IFN-β compared with H1C (Figure 6A), 
which was consistent with the results of the virus replication. To 
better understand the role of T146, K34, and K187 residues on 
the regulation of IFN-β, A549-H1C-KO cells were used. The data 
showed that IFN-β level in A549-H1C-KO cells was much lower 
than A549-WT cells, and it was significantly increased to a level 
that was similar to wild-type cells when H1C was overexpressed. 
Expectedly, K34A and K187A mutations significantly enhanced 
the ability of H1C to induce IFN-β, while T146A mutations 
significantly inhibited this induction (Figure 6B). Silencing or 
expression levels of H1C were detected using western blotting 
analyses.
Influenza virus can be recognized by RIG-I during infection 
and activates type-I interferon production by signaling transduc-
tion from RIG-I, MAVS, and TBK1/IKK-ξ complex to IRF3. To 
investigate how H1C regulates IFN-β, the IFN-β induction sign-
aling pathway was analyzed. When co-transfected with the above 
factors and siRNA, H1C or its mutants on A549 cells, we found 
that IFN-β levels stimulated by all these factors were significantly 
influenced by H1C. For example, when stimulated with RIG-I, 
IFN-β production was significantly reduced by silencing H1C, 
but it was significantly increased by overexpression of H1C. In 
addition, K34A and K187A mutations significantly promoted the 
effect of H1C, while the T146A mutation significantly inhibited the 
effect (Figure 7A). Similar results were also observed when tested 
with MAVS (Figure 7B), TBK-1 (Figure 7C), IKK-ξ (Figure 7D), 
and IRF3 (Figure 7E). These findings indicated that H1C could 
affect IFN-β via IRF3. However, because IRF7 is also involved 
in IFN-β activation, the effect of H1C on IFN-β stimulated by 
IRF7 should be detected to confirm whether H1C regulates 
IFN-β specifically via IRF3. Unfortunately, IFN-β activated by 
IRF7 was slightly affected by overexpression or silencing of H1C 
(Figure 7F), indicating that H1C regulated IFN-β specifically via 
IRF3. The expression of each factor and the silencing efficiency or 
expression levels of H1C were detected by western blotting and 
are shown below.
h1c affects irF3 Binding onto the  
iFn-β Promoter
During influenza virus infection, IRF3 is phosphorylated and 
transported into the nucleus to bind onto the IFN-β promoter 
FigUre 5 | analysis of the effects of h1c on cytokines and chemokines. A549 cells were transfected with small interfering RNA (siRNA), H1C or its mutants 
and were harvested at 24 h later. The mRNA of target genes [interferon-β (IFN-β), IL-6, IL-8, TNF-α, OASL, MX1, and CXCL10] were detected using real-time PCR, a 
non-target siRNA (Si-NC), and the siRNA targeted to GAPDH (Si-GAPDH) were used as a negative or positive control to detect the silencing specificity of H1C 
(*p < 0.05, **p < 0.01, the data were generated from three independent experiments).
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and activate IFN-β production. Thus, to determine how H1C 
regulates IFN-β via IRF3, the effect of H1C on IRF3 phospho-
rylation was first detected. Unexpectedly, H1C showed a slight 
effect on IRF3 or IRF3 phosphorylation levels (Figure 8A). Thus, 
the effect of H1C on the nucleus transportation of phosphoryl-
ated IRF3 was investigated. These data showed that the level of 
phosphorylated IRF3 in the nucleus was significantly increased 
when overexpressing H1C, which was weakened by T146A. 
Unexpectedly, K34A and K187A mutation did not enhance this 
process. At the same time, we observed contrasting results with 
regard to the amount of IRF3-P in the cytoplasm, which was the 
opposite to findings observed in the nucleus and was much lower 
FigUre 6 | investigation of the effects of h1c on interferon-β (iFn-β) in a549 or a549-h1c-KO cells. (a) A549 cells transfected with small interfering RNA 
(siRNA), H1C or its mutants were stimulated with poly(I: C) (20 nmol/mL) for 6 h, and IFN-β mRNA levels were detected using real-time PCR. A non-target siRNA 
(Si-NC) and the siRNA targeted to GAPDH (Si-GAPDH) were used as the negative or positive control to detect the silencing specificity of H1C. (B) A549-H1C-KO 
cells were overexpressed with H1C or its mutants and stimulated with poly (I:C) as described above, and IFN-β mRNA levels were then detected. H1C silencing or 
expression levels were detected by western blotting (*p < 0.05, **p < 0.01, the data were generated from three independent experiments).
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when overexpressing H1C or its mutants (Figure 8B). K34A and 
K187A mutants did not promote IRF3-P nuclear transporta-
tion compared with H1C, which indicated that H1C might 
regulate IFN-β by affecting IRF3 phosphorylation and nuclear 
transportation. To further explain this question, we determined 
whether H1C interacted with IRF3-P and affected its subsequent 
functions. To achieve this suppose, HA-IRF3 and Flag-H1C 
or its mutants were co-expressed and Co-IP experiments were 
performed in HEK293T cells. To our surprise, the data showed 
that H1C interacted with IRF3-P. Interestingly, the methylation 
mutants (K34A, K187A) showed a stronger ability to interact 
with IRF3-P than H1C wild type, and the phosphorylation muta-
tion appeared weakened this interaction (Figure  8C). Further 
experiments showed that H1C and its mutants co-localized with 
IRF3-P in the nucleus (Figure 8D). This finding suggested that 
H1C might affect IRF3 binding onto the IFN-β promoter via its 
interaction. To confirm this speculation, HA-IRF3 and Flag-H1C 
or its mutants were co-expressed and chromatin immunoprecipi-
tation was performed in HEK293T cells. The data showed that 
K34A and K187A mutants significantly enhanced the ability of 
IRF3 to bind onto IFN-β promoter (Figure 8E). Taken together, 
these data revealed that H1C regulated IFN-β by affecting IRF3 
nuclear transportation and IFN-β promoter binding.
ns2 inhibits iFn-β enhanced by h1c
Would NS2 be involved in the H1C regulation of IFN-β? To deter-
mine this, NS2 was expressed individually or co-expressed with 
H1C and the effect of NS2 on IFN-β was detected. The data showed 
that NS2 slightly affected IFN-β production when overexpressed 
alone, but it significantly reduced IFN-β when co-expressed with 
H1C (Figure 9A), indicating that NS2 is involved in the regulation 
of H1C on IFN-β. Thus, the effect of NS2 on IRF3 phosphorylation 
when co-expressed with H1C was evaluated. The result showed 
that NS2 significantly decreased IRF3 phosphorylation levels when 
co-expressed with H1C or its mutants compared with the vector. 
But, when NS2 was expressed with H1C, the IRF3 phosphorylation 
levels was sharply decreased, and similar results were found in the 
K34A and K187A mutant groups. However, the IRF3 levels were 
higher compared to the vector groups (Figure  9B, a). In addi-
tion, NS2 slightly affected IRF3 expression or phosphorylation 
when overexpressed alone (Figure 9B, c). Because H1C interacts 
with both NS2 and IRF3-P, which suggests that NS2 might affect 
H1C–IRF3 interaction; thus, NS2 was co-expressed with H1C 
and IRF3, and Co-IP experiments were performed to detect the 
potential effect of NS2 on H1C–IRF3 interaction. These results 
showed that NS2 reduced the interactions between IRF3 and H1C 
or its mutants (Figure  9B, b) indicating that NS2 might affect 
IRF3 binding onto the IFN-β promoter when expressed with H1C. 
Further experiments were performed to investigate this question, 
and these result showed that NS2 significantly inhibited the abil-
ity of IRF3 to bind onto the IFN-β promoter when co-expressed 
with H1C, and it also inhibited the ability of IRF3 to bind onto the 
IFN-β promoter when co-expressed with K34A, T146A or K187A 
but without significance (Figure  9C), indicating that inhibition 
of NS2 on IFN-β induced by H1C relied on the methylation and 
phosphorylation of H1C.
FigUre 7 | interferon-β (iFn-β)-inducing signaling pathway analysis. (a) A549 cells cultured in 12-well plates were co-transfected with RIG-I (1 µg), H1C 
(1 µg) or its mutants, and small interfering RNA (siRNA) (40 pmol), and the IFN-β mRNA levels were detected by RT-PCR 24 h later. A non-target siRNA (Si-NC) and 
the siRNA targeted to GAPDH (Si-GAPDH) were used as a negative or positive control to detect the silencing specificity of H1C. (B) Analysis of the effect of H1C or 
its mutants on IFN-β stimulated by MAVS using real-time PCR. (c) Analysis of the effect of H1C or its mutants on IFN-β stimulated by TBK-1 using real-time PCR. 
(D) Analysis of the effect of H1C or its mutants on IFN-β stimulated by IKK-ξ using real-time PCR. (e) Analysis of the effect of H1C on IFN-β stimulated by IRF3 using 
real-time PCR. (F) Analysis of the effect of H1C or its mutants on IFN-β stimulated by IRF7 using real-time PCR. H1C silencing or expression and RIG-I, MAVS, 
TBK1, IKK-ξ, IRF3, and IRF7 expression levels were detected by western blotting (*p < 0.05, **p < 0.01, ***p < 0.001, the data were generated from three 
independent experiments).
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DiscUssiOn
The innate immune response is an important defense 
for the host against viral infection during the early stage, 
which includes the activation of interferon, inflammation, 
chemokines, and other antiviral factors. Here, we find that H1C 
not only affects IFN-β but also TNF-α and CXCL10, indicating 
that H1C is a multifunctional factor. TNF-α plays crucial roles 
in the regulation of inflammation, and it induces apoptosis 
by activating the JNK/Caspase signaling pathway. Influenza 
virus replication can lead to cell apoptosis and inflammation; 
and apoptosis is not conduce to influenza virus replication at 
the early stage while it promotes virus release from the cell 
at the later stage; in addition, inflammation can accelerates 
host cell to clear the infection (27). A recent study showed 
that IKK inhibits TNFα-induced apoptosis via two distinct 
but cooperative mechanisms: activation of the survival factor 
NF-κB and inactivation of the proapoptotic BH3-only BAD 
FigUre 8 | The mechanism of h1c regulating interferon-β (iFn-β). (a) Analysis of the effects of H1C and its mutants on IRF3 and IRF3 phosphorylation. 
Human embryonic kidney 293 T (HEK293T) cells were overexpressed with H1C or its mutants and infected with Sendai virus (Sev) for an additional 12 h. IRF3 and 
IRF3 phosphorylation levels were then detected by western blotting using anti-IRF3 (sc-33642, Santa Cruz Biotechnology, Santa Cruz, CA, USA) or anti-IRF3-P 
antibody (Cat.#07-582-I, Millipore, Billerica, MA, USA). (B) Analysis of the effect of H1C on IRF3 nuclear transportation. HEK293T cells were treated as described 
above, and the cytoplasm and nuclear fractions were separated. IRF3 phosphorylation levels were then detected. (c) Detection of H1C–IRF3-P interactions; 
HEK293T cells co-transfected with HA-IRF3 and Flag-H1C or its mutants were infected with Sev for 12 h, and the co-immunoprecipitation (Co-IP) experiments were 
performed using anti-flag antibody and analyzed by western blotting using the anti-IRF3-P antibody to detect its interaction. (D) Investigation of co-localizations 
between H1C and IRF3-P. A549 cells cultured on slides were co-transfected with HA-IRF3 and Flag-H1C or its mutants and stimulated with poly (I:C) for 6 h, and 
immunofluorescence confocal microscopy was performed as previously described using anti-Flag mouse monoclonal antibody and anti-HA rabbit polyclonal 
antibody followed by immunostaining with FITC-labeled goat anti-mouse secondary antibody and Cy3-labeled goat anti-rabbit antibody. (e) Chromatin 
immunoprecipitation and quantitation PCR was performed to detect the effects of H1C on the capacity of IRF3 binding to the IFN-β promoter. HEK293T cells were 
co-transfected with HA-IRF3, and Flag-H1C or H1C mutants and chromatin immunoprecipitation assay were performed using am anti-HA antibody; the negative 
control was performed using the mouse IgG antibody, and the positive control was conducted using the anti-poly II antibody (*p < 0.05, the data were generated 
from one of three independent experiments).
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protein (28). These findings suggest that H1C is involved in 
the regulation of apoptotic and inflammation by regulating 
TNF-α or other pathways related to TNF-α, thereby affect-
ing influenza viral replication. In addition, CXCL10 exhibits 
chemo-attractive effects on macrophages, T  cells, NK  cells, 
and dendritic cells, which promotes the host to clear infection. 
And CXCL10 binds to a common receptor chemokine (C–X–C 
motif) receptor 3 (CXCR3) and activates multiple functions 
of CD8+ T  cells (29). Moreover, CXCR3 has been found to 
be important in the pathogenesis of several viral infections, 
including influenza (30). These findings suggest that H1C can 
regulates influenza viral replication via different methods, and 
it also suggests that H1C may be involved in the regulation 
of other viruses.
Three distinct families of transcription factors, including 
nuclear factor-κB (NF-κB), activating transcription factor 2/c-
Jun, and IRF3, are involved in IFN-β transcription (31). Of these, 
IRF3 plays a crucial role in the induction of IFN-β. H1C slightly 
affects IRF3 phosphorylation but promotes IRF3 nuclear trans-
portation, which increases IFN-β production. However, K34A 
and K187A mutants appear to have little effect on IRF3 nuclear 
transportation compared with H1C wild type but increase the 
ability of IRF3 binding onto the IFN-β promoter, indicating that 
H1C regulates IFN-β by affecting IRF3 nuclear transportation 
and IRF3 binding onto the IFN-β promoter. H1C might recruit 
IRF3 binding onto IFN-β promoter by interacting with IRF3. It 
may change the structure of the nucleosome via its simultaneous 
phosphorylation and methylation; thus, H1C phosphorylation 
FigUre 9 | ns2 inhibits interferon-β (iFn-β) induced by h1c. (a) Investigation of the effect of NS2 on IFN-β stimulated by H1C. A549 cells were transfected 
with pCAGGS and pCAGGA-NS2 individually, or co-transfected with p3xflag or H1C, then stimulated by poly (I:C) (20 nmol/mL) for 6 h, and IFN-β mRNA was 
detected by real-time PCR. (B) NS2 affects IRF3 phosphorylation and H1C–IRF3-P interaction. (a) Human embryonic kidney 293 T (HEK293T) cells co-expressed 
with NS2 and H1C or its mutants were infected with Sendai virus (Sev) for 10 h. Next, the cells were lysed, and IRF3 and IRF3-P levels were detected by western 
blotting, respectively; (b) cells were treated as described above, and co-immunoprecipitation (Co-IP) experiments were performed to detect the effect of NS2 on the 
H1C–IRF3-p interaction; (c) detection of the effect of NS2 on IRF3 and IRF3 phosphorylation. Human embryonic kidney 293 T cells were transfected with pCAGGS 
or pCAGGS-NS2 and infected with Sev for 12 h. IRF3 and IRF3 phosphorylation levels were detected by western blotting. (c) Analysis of the effects of NS2 on the 
ability of IRF3 to bind to the IFN-β promoter by chromatin immunoprecipitation and quantitation PCR. HEK293T cells co-transfected with IRF3, NS2, and H1C or its 
mutants and stimulated by Sev, and the chromatin immunoprecipitation assay was performed using anti-IRF3-P antibody. The negative control was performed using 
the mouse IgG antibody, and the positive control was performed using the anti-poly II antibody (*p < 0.05, ***p < 0.001, the data were generated from one of three 
independent experiments).
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may release the nucleosome and promote polymerase II (poly II) 
(32) and IRF3 binding onto the IFN-β promoter to start tran-
scription (Figure 10, a). Conversely, H1C methylation may make 
the nucleosome tighter, preventing IRF3 binding onto the IFN-β 
promoter (Figure 10, b) and suggesting that H1C is involved in 
epigenetic regulation of the gene via its phosphorylation and 
methylation. Thus, the equilibrium of H1C phosphorylation and 
methylation is important for its effect on IFN-β. Similar studies 
have also found that histones are involved in epigenetic regula-
tion; for example, HP1-beta genome-wide localization follows 
H3K9me3-enrichment, and the artificial bridging of chromatin 
fibers is sufficient to maintain cellular heterochromatic confor-
mation (33, 34). DNA methylation plays an unexpected dual role 
at enhancer regions and is anti-correlated focally at transcription 
factor-binding sites but positively correlated globally with the 
active H3K27ac mark to ensure structural enhancer integrity 
(35, 36).
In addition, it has been found that mice embryos lacking the 
three H1 subtypes (H1C, H1D, and H1E) die by mid-gestation 
with a broad range of defects (37), and mutations in HIST1H1 
B-E closely related to the pathogenesis of follicular lymphoma 
(38). These findings suggest that the mutations and modifica-
tions of H1C involve in a wide range of regulations. Moreover, 
a recent study has identified a H1C SNP variant A18V in MCF-
10A cells (39) while Linder found that alanine at position 17 
in H1.2 was replaced by valine in K562 erythroleukemic cells 
(40), but the function of these variants in innate immunity were 
not clear.
On the other hand, a recent study found that the NS1 protein 
of influenza A H3N2 subtype exhibits a histone-like sequence 
(histone mimic), which is used by the virus to target the human 
PAF1 transcription elongation complex (hPAF1C), resulting in 
the suppression of hPAF1C-mediated transcriptional elongation 
and contributing to the suppression of the antiviral response 
FigUre 10 | The schematic diagram of h1c regulating interferon-β (iFn-β) and the function of ns2 in it. When IRF3 is phosphorylated and transported 
into the nucleus, it recruits co-factors and binds to the IFN-β promoter to start the IFN-β transcription. (a) When H1C is phosphorylated, it opens the nucleosome 
and makes it looser, which promotes IRF3 binding to the IFN-β promoter and induces more IFN-β production; (b) when H1C is methylated, it brings the nucleosome 
structure closer, which inhibits IRF3 binding to the IFN-β promoter and decreases IFN-β production; (c) in addition, NS2 interacts with phosphorylated H1C, which 
reduces the H1C–IRF3 interaction and results in an inhibition of IRF3 binding to the IFN-β promoter and less IFN-β production; (d) NS2 interacts with methylated 
H1C, which promotes the interaction between H1C and IRF3 and enhances the inhibition of IFN-β production.
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(41). However, it is a unique mechanism and not suit for the 
other influenza virus strains. In this study, NS2 reduces IRF3 
phosphorylation and H1C–IRF3 interaction when co-expressed 
with H1C, indicating that NS2 is involved in the regulation of 
IFN-β by decreasing IRF3 phosphorylation and comparatively 
interacting with H1C or its mutants, thereby reducing the 
H1C–IRF3 interaction and further affecting IRF3 binding onto 
the IFN-β promoter as a result of decreases in IFN-β produc-
tion (Figure 10, c and d). However, the ability of IRF3 to bind 
to the IFN-β promoter was only slightly decreased by NS2 when 
K34, T146, and K187 were mutated. This may because K34A and 
K187A mutants have stronger ability to promote IRF3-P to bind 
onto IFN-β promoter thereby produce much higher IFN-β; thus, 
when NS2 co-expressed with K34A or K187A mutants, it could 
only decrease the ability of IRF3 binding onto IFN-β promoter to 
some degree though it can decrease IRF3-P levels and H1C–IRF3 
interactions significantly. And when co-expressed with T146A 
mutant, NS2 showed slightly inhibition to the ability of IRF3 to 
bind onto IFN-β promoter because the T146A mutation could 
significantly decrease the ability of IRF3 to bind onto IFN-β 
promoter itself. These findings indicate that NS2 inhibits IFN-β 
induced by H1C and is dependent on the phosphorylation and 
methylation of H1C to some degree.
In summary, we identified a novel function of H1C in the 
innate immune response and uncovered the mechanism. We also 
demonstrated that NS2 is involved in this process, revealing a 
new approach for influenza A virus to evade the innate immune 
response.
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